1. Home
  2. RSVR vs NGNE Comparison

RSVR vs NGNE Comparison

Compare RSVR & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reservoir Media Inc.

RSVR

Reservoir Media Inc.

N/A

Current Price

$10.10

Market Cap

681.9M

ML Signal

N/A

Logo Neurogene Inc.

NGNE

Neurogene Inc.

N/A

Current Price

$22.27

Market Cap

744.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RSVR
NGNE
Founded
2007
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
681.9M
744.9M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
RSVR
NGNE
Price
$10.10
$22.27
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$13.00
★ $77.63
AVG Volume (30 Days)
53.1K
★ 242.2K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8.33
0.93
EPS
★ 0.07
N/A
Revenue
★ $175,664,491.00
N/A
Revenue This Year
$8.25
N/A
Revenue Next Year
$5.49
N/A
P/E Ratio
$145.43
★ N/A
Revenue Growth
★ 10.69
N/A
52 Week Low
$7.15
$15.93
52 Week High
$13.39
$43.66

Technical Indicators

Market Signals
Indicator
RSVR
NGNE
Relative Strength Index (RSI) 54.03 36.47
Support Level $9.98 $21.05
Resistance Level $10.22 $23.35
Average True Range (ATR) 0.38 1.80
MACD -0.02 -0.21
Stochastic Oscillator 33.82 3.13

Price Performance

Historical Comparison
RSVR
NGNE

About RSVR Reservoir Media Inc.

Reservoir Media Inc is an independent music company. The company operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the U.S. Music Publishing segment engaged in the acquisition of interests in music catalogs to earn royalties and signing songwriters to agreements of future delivery of songs. The Recorded Music segment involve the acquisition of sound recording catalogs and the discovery and development of recording artists and the marketing, distribution, sale and licensing of the music catalog.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Share on Social Networks: